ConvaTec Group PLC (LON:CTEC) Insider Karim Bitar Sells 436,692 Shares of Stock

ConvaTec Group PLC (LON:CTEC) insider Karim Bitar sold 436,692 shares of the firm’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of GBX 256 ($3.33), for a total transaction of £1,117,931.52 ($1,453,369.11).

Karim Bitar also recently made the following trade(s):

• On Friday, March 14th, Karim Bitar sold 132,253 shares of ConvaTec Group stock. The stock was sold at an average price of GBX 256 ($3.33), for a total transaction of £338,567.68 ($440,155.59).

ConvaTec Group Trading Up 0.5 %

LON:CTEC opened at GBX 259.40 ($3.37) on Wednesday. ConvaTec Group PLC has a 12 month low of GBX 211.80 ($2.75) and a 12 month high of GBX 295.20 ($3.84). The stock has a market cap of £6.60 billion, a price-to-earnings ratio of 43.68, a P/E/G ratio of 0.93 and a beta of 0.64. The company has a 50-day moving average price of GBX 246.42 and a 200-day moving average price of GBX 234.53. The company has a current ratio of 2.26, a quick ratio of 0.96 and a debt-to-equity ratio of 85.32.

ConvaTec Group Increases Dividend

The firm also recently declared a dividend, which will be paid on Thursday, May 29th. Investors of record on Thursday, April 17th will be given a dividend of $0.05 per share. This is a boost from ConvaTec Group’s previous dividend of $0.02. This represents a yield of 1.36%. The ex-dividend date is Thursday, April 17th. ConvaTec Group’s dividend payout ratio (DPR) is 84.20%.

Wall Street Analyst Weigh In

Separately, Berenberg Bank reaffirmed a “buy” rating and issued a GBX 310 ($4.03) target price on shares of ConvaTec Group in a research report on Wednesday, March 5th.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.